Artivion, Inc. (AORT) — Analysis Summary
Artivion, Inc. (AORT) has a market cap of $1.17B with year-over-year revenue growth of +13.6%. Net margin stands at 2.2%. The stock trades at a P/E ratio of 99.8.
Key Takeaways
- Revenue changed +13.6% year-over-year
- Net margin of 2.2%
- P/E ratio of 99.8
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, AORT posted revenue growth of +13.6% and trades at a P/E of 99.8.
Artivion, Inc. (AORT)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsWatch List
Some caution signals are active and should be weighed alongside the valuation work.
Interest coverage at 1.5x — limited headroom for earnings decline
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
1,800
Headquarters
KENNESAW, GA
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$0.12
Dividend Yield
0.52%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.